Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2021
Filter by date:
Showing 973 press releases before 2021
-
Lynparza Phase III PROfound trial in HRR* mutation-selected metastatic castration-resistant prostate cancer met primary endpoint
-
Forxiga label updated in the EU in type-2 diabetes
-
H1 2019 Results
-
Update on US regulatory decision for Farxiga in type-1 diabetes
-
Imfinzi granted US Orphan Drug Designation for small cell lung cancer
-
Forxiga receives positive EU CHMP opinion for DECLARE-TIMI 58 cardiovascular outcomes data
-
Fasenra receives positive EU CHMP opinion for self-administration and the new Fasenra pen, a pre-filled, single-use auto-injector
-
Imfinzi improves overall survival at interim analysis in the Phase III CASPIAN trial in 1st-line extensive-stage small cell lung cancer
-
Breztri Aerosphere (PT010) approved in Japan for patients with chronic obstructive pulmonary disease
-
Lynparza approved in Japan for 1st-line maintenance therapy in BRCA-mutated advanced ovarian cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
